PIK3CA and head and neck squamous cell carcinoma: The mere evidence regarding the G1633A mutation in PIK3CA was that the G1633A mutation inhibited apoptosis in HNSCC cell lines treated with AG1478, an inhibitor of EGFR tyrosine kinase.